Nova Biomedical Executive and Leadership Team

Byron Selman, the President & Chief Executive Officer at Nova Biomedical, directs the overarching strategic vision and global commercialization efforts for the company. Overseeing the development of critical care blood gas analyzers and cell culture monitoring systems, the President & Chief Executive Officer ensures alignment between engineering innovation and clinical market requirements. This leadership role involves managing complex international operations while maintaining the high standards of quality expected in the medical device industry. By fostering a culture of technical excellence, Byron Selman drives the expansion of the product portfolio into new biopharmaceutical sectors. The President & Chief Executive Officer coordinates with the board to secure long-term growth and operational stability. Through rigorous oversight of manufacturing processes and customer service initiatives, Selman maintains the competitive edge of the organization within the global diagnostic landscape, ensuring that every analytical instrument meets the precise needs of modern healthcare providers.

Lou Borrelli, the Senior Vice President & Chief Financial Officer at Nova Biomedical, manages the fiscal health and capital allocation strategies for the organization. Overseeing global financial planning and analysis, the Senior Vice President & Chief Financial Officer ensures the availability of resources for the development of innovative in vitro diagnostic devices. This leadership role involves monitoring market trends in the biopharmaceutical sector to guide investment in new manufacturing capabilities and research initiatives. By optimizing cost structures and revenue streams, Lou Borrelli supports the sustainable growth of the company across international markets. The Senior Vice President & Chief Financial Officer coordinates with executive leadership to evaluate the financial viability of new product launches and expansion projects. Through disciplined fiscal management, Borrelli secures the capital necessary to maintain the company's position as a leader in critical care blood gas analysis. This strategic financial oversight directly enables the continued delivery of high-quality medical technology to healthcare providers worldwide.

Peter Soltani, the President at Nova Biomedical, manages the operational execution and market-specific strategies for the company's diverse portfolio of diagnostic devices. Overseeing the commercialization of point-of-care meters and cell culture monitoring systems, the President ensures that product development cycles meet the evolving demands of the biopharmaceutical industry. This leadership role involves driving regional market penetration and strengthening relationships with key clinical partners. By streamlining the transition from research to manufacturing, Peter Soltani accelerates the delivery of innovative solutions to the global market. The President coordinates with cross-functional teams to ensure that all analytical instruments adhere to rigorous regulatory standards and performance benchmarks. Through the implementation of efficient operational processes, Soltani enhances the company's ability to scale production and meet the needs of healthcare providers. This focus on operational excellence and market growth directly contributes to the mission of enhancing patient care through the application of advanced diagnostic technology.

Thomas MacDougall, the Chief Information Officer at Nova Biomedical, architects the digital infrastructure supporting the manufacturing and distribution of advanced analytical instruments. Overseeing the integration of data systems across global facilities, the Chief Information Officer ensures secure and efficient information flow for clinical and biopharmaceutical operations. This leadership role involves implementing robust cybersecurity protocols to protect proprietary diagnostic technology and sensitive research data. By modernizing internal software platforms, Thomas MacDougall optimizes the supply chain and enhances the connectivity of point-of-care meters used in clinical settings. The Chief Information Officer collaborates with engineering teams to support the digital transformation of diagnostic devices, ensuring seamless data integration for end-users. Through the deployment of scalable cloud solutions, MacDougall drives operational efficiency and supports the company's mission to provide cutting-edge technology. This focus on digital excellence remains central to maintaining the technological leadership of the organization in the competitive medical device market.

Michele Buonopane, the Chief Human Resources Officer at Nova Biomedical, directs the talent acquisition and organizational development strategies required to support a global medical device manufacturer. Overseeing the recruitment of specialized engineering and clinical research personnel, the Chief Human Resources Officer ensures the company maintains a workforce capable of advancing complex diagnostic technologies. This leadership role involves designing comprehensive training programs that align with the company's commitment to quality and customer service. By fostering an inclusive and high-performance culture, Michele Buonopane drives employee engagement and retention across all operational regions. The Chief Human Resources Officer collaborates with department heads to implement performance management systems that reward innovation and technical expertise. Through the development of robust human capital strategies, Buonopane supports the long-term objectives of the organization. This focus on building a skilled and motivated team remains essential for the successful commercialization of advanced analytical instruments and the continued growth of the company in the competitive healthcare sector.